Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy. 1986

S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa

Two patients diagnosed as having acute promyelocytic leukemia (APL) and disseminated intravascular coagulation (DIC) were closely followed by serial fibrinolysis and coagulation studies from the day of admission until completion of the first course of chemotherapy. One patient was treated with intravenous heparin and Trasylol (Bayer AG, West Germany) and the other received heparin therapy without Trasylol. In Patient 1, hyperfibrinolytic activity, not observed during the administration of Trasylol, developed with its discontinuance. In Patient 2, hyperfibrinolysis was observed coincidentally with a decrease in APL cells due to chemotherapy. These results indicate that hyperfibrinolysis in APL is not associated with DIC.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
August 1971, American journal of clinical pathology,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
March 2012, American journal of hematology,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
November 1997, Hematological oncology,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
March 1977, Harefuah,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
March 1976, Wiadomosci lekarskie (Warsaw, Poland : 1960),
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
April 1974, Annals of internal medicine,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
May 1992, Thrombosis research,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
September 1991, Revista medica de Chile,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
January 1979, Nouvelle revue francaise d'hematologie,
S Imaoka, and T Ueda, and H Shibata, and T Masaoka, and M Ogawa, and Y Sasaki, and T Iwanaga, and T Terasawa
January 1978, Nouvelle revue francaise d'hematologie,
Copied contents to your clipboard!